Literature DB >> 18292233

Regulation of arterial-venous differences in tumor necrosis factor responsiveness of endothelial cells by anatomic context.

Meng Liu1, Martin S Kluger, Alessio D'Alessio, Guillermo García-Cardeña, Jordan S Pober.   

Abstract

We analyzed tumor necrosis factor (TNF) responses of human umbilical artery and vein endothelial cells (HUAECs and HUVECs) in organ and cell culture. In organ culture, TNF induced expression of E-selectin, VCAM-1, and ICAM-1 on HUVECs but only ICAM-1 on HUAECs. Activation of nuclear factor-kappaB, c-jun, and ATF2 by TNF was comparable in HUAECs and HUVECs, whereas binding of transcription factors and p300 co-activator to the E-selectin enhancer was lower in HUAECs compared to HUVECs. In cell culture, HUAECs rapidly acquired inducible E-selectin and VCAM-1 whereas ICAM-1 inducibility decreased. Culture of HUVECs rapidly decreased TNF responses of all three genes. By 72 hours in cell culture, TNF-treated HUVECs and HUAECs showed comparable adhesion molecule induction and transcription factor binding to the E-selectin enhancer. Freshly isolated HUAECs expressed higher levels of Kruppel-like factor 2 (KLF2) than HUVECs, consistent with greater KLF2 induction by arterial levels of shear stress in vitro. KLF2 expression decreased rapidly in both cell types during culture. Transduction of HUVECs with KLF2 reduced TNF-mediated induction of E-selectin and VCAM-1 while increasing ICAM-1 induction and reduced transcription factor/co-activator binding to the E-selectin enhancer. In conclusion, the differential responses of HUAECs and HUVECs to TNF in organ culture correlate with transcription factor/co-activator binding to DNA and converge during cell culture. Flow-induced expression of KLF2 contributes to the in situ responses of HUAECs but not of HUVECs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292233      PMCID: PMC2276407          DOI: 10.2353/ajpath.2008.070603

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2.

Authors:  Joost O Fledderus; Johannes V van Thienen; Reinier A Boon; Rob J Dekker; Jakub Rohlena; Oscar L Volger; Ann-Pascale J J Bijnens; Mat J A P Daemen; Johan Kuiper; Theo J C van Berkel; Hans Pannekoek; Anton J G Horrevoets
Journal:  Blood       Date:  2007-01-23       Impact factor: 22.113

2.  Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways.

Authors:  M R Slowik; W Min; T Ardito; A Karsan; M Kashgarian; J S Pober
Journal:  Lab Invest       Date:  1997-09       Impact factor: 5.662

3.  TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways.

Authors:  W Min; J S Pober
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

4.  Kruppel-like factor 2 transcriptional regulation involves heterogeneous nuclear ribonucleoproteins and acetyltransferases.

Authors:  Nisar Ahmad; Jerry B Lingrel
Journal:  Biochemistry       Date:  2005-04-26       Impact factor: 3.162

Review 5.  Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.

Authors:  T Collins; M A Read; A S Neish; M Z Whitley; D Thanos; T Maniatis
Journal:  FASEB J       Date:  1995-07       Impact factor: 5.191

6.  Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells.

Authors:  M R Slowik; L G De Luca; W Min; J S Pober
Journal:  Circ Res       Date:  1996-10       Impact factor: 17.367

7.  CREB-binding protein/p300 are transcriptional coactivators of p65.

Authors:  M E Gerritsen; A J Williams; A S Neish; S Moore; Y Shi; T Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter.

Authors:  L G De Luca; D R Johnson; M Z Whitley; T Collins; J S Pober
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

9.  A striking similarity in the organization of the E-selectin and beta interferon gene promoters.

Authors:  M Z Whitley; D Thanos; M A Read; T Maniatis; T Collins
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

10.  Functional analysis of the human vascular cell adhesion molecule 1 promoter.

Authors:  A S Neish; A J Williams; H J Palmer; M Z Whitley; T Collins
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  20 in total

1.  Leukocyte rolling and adhesion via ICAM-1 signals to endothelial permeability. Focus on "Leukocyte rolling and adhesion both contribute to regulation of microvascular permeability to albumin via ligation of ICAM-1".

Authors:  Marcie R Williams; Francis W Luscinskas
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-20       Impact factor: 4.249

Review 2.  Participation of blood vessel cells in human adaptive immune responses.

Authors:  Jordan S Pober; George Tellides
Journal:  Trends Immunol       Date:  2011-10-24       Impact factor: 16.687

3.  MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells.

Authors:  Paul R Clark; Todd J Jensen; Martin S Kluger; Maurice Morelock; Adedayo Hanidu; Zhenhao Qi; Revati J Tatake; Jordan S Pober
Journal:  Microcirculation       Date:  2011-02       Impact factor: 2.628

4.  Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention.

Authors:  Jorge Gracia-Sancho; Guadalupe Villarreal; Yuzhi Zhang; Jessica X Yu; Yao Liu; Stefan G Tullius; Guillermo García-Cardeña
Journal:  Transplantation       Date:  2010-07-27       Impact factor: 4.939

5.  Direct-contact co-culture between smooth muscle and endothelial cells inhibits TNF-alpha-mediated endothelial cell activation.

Authors:  Charles S Wallace; George A Truskey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-21       Impact factor: 4.733

Review 6.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.

Authors:  Jeng-Jiann Chiu; Shu Chien
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 7.  Renal microvascular endothelial cell responses in sepsis-induced acute kidney injury.

Authors:  Grietje Molema; Jan G Zijlstra; Matijs van Meurs; Jan A A M Kamps
Journal:  Nat Rev Nephrol       Date:  2021-10-19       Impact factor: 28.314

8.  ArhGEF12 activates Rap1A and not RhoA in human dermal microvascular endothelial cells to reduce tumor necrosis factor-induced leak.

Authors:  Alamzeb Khan; Weiming Ni; Tania Baltazar; Francesc Lopez-Giraldez; Jordan S Pober; Richard W Pierce
Journal:  FASEB J       Date:  2022-04       Impact factor: 5.834

9.  Endothelial MEKK3-KLF2/4 signaling integrates inflammatory and hemodynamic signals during definitive hematopoiesis.

Authors:  Yiqing Yang; Melanie Mumau; Joanna Tober; Qin Zhu; Laura Bennett; Courtney Hong; Derek Sung; Thomas Keller; Yasin Uzun; Peng Gao; Swapnil Shewale; Mei Chen; Jisheng Yang; Xiaowen Chen; Steven A Thomas; Kai Tan; Nancy A Speck; Mark L Kahn
Journal:  Blood       Date:  2022-05-12       Impact factor: 25.476

10.  Endothelial Msx1 transduces hemodynamic changes into an arteriogenic remodeling response.

Authors:  Ine Vandersmissen; Sander Craps; Maarten Depypere; Giulia Coppiello; Nick van Gastel; Frederik Maes; Geert Carmeliet; Jan Schrooten; Elizabeth A V Jones; Lieve Umans; Roland Devlieger; Michel Koole; Olivier Gheysens; An Zwijsen; Xabier L Aranguren; Aernout Luttun
Journal:  J Cell Biol       Date:  2015-09-21       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.